|
US6248713B1
(en)
*
|
1995-07-11 |
2001-06-19 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
US6037324A
(en)
*
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
CA2261974A1
(en)
|
1996-07-25 |
1998-02-05 |
Biogen, Inc. |
Molecular model for vla-4 inhibitors
|
|
US6686350B1
(en)
|
1996-07-25 |
2004-02-03 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
US6221888B1
(en)
|
1997-05-29 |
2001-04-24 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
|
ATE318841T1
(de)
*
|
1997-05-29 |
2006-03-15 |
Merck & Co Inc |
Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
|
|
US6903075B1
(en)
|
1997-05-29 |
2005-06-07 |
Merck & Co., Inc. |
Heterocyclic amide compounds as cell adhesion inhibitors
|
|
US6291511B1
(en)
|
1997-05-29 |
2001-09-18 |
Merck & Co., Inc. |
Biarylalkanoic acids as cell adhesion inhibitors
|
|
WO1998054207A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
|
US6939855B2
(en)
*
|
1997-07-31 |
2005-09-06 |
Elan Pharmaceuticals, Inc. |
Anti-inflammatory compositions and method
|
|
US6362341B1
(en)
|
1997-07-31 |
2002-03-26 |
Athena Neurosciences, Inc. |
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6492421B1
(en)
|
1997-07-31 |
2002-12-10 |
Athena Neurosciences, Inc. |
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6291453B1
(en)
|
1997-07-31 |
2001-09-18 |
Athena Neurosciences, Inc. |
4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6559127B1
(en)
|
1997-07-31 |
2003-05-06 |
Athena Neurosciences, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6489300B1
(en)
|
1997-07-31 |
2002-12-03 |
Eugene D. Thorsett |
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US7030114B1
(en)
|
1997-07-31 |
2006-04-18 |
Elan Pharmaceuticals, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6423688B1
(en)
|
1997-07-31 |
2002-07-23 |
Athena Neurosciences, Inc. |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6583139B1
(en)
|
1997-07-31 |
2003-06-24 |
Eugene D. Thorsett |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
AR016133A1
(es)
*
|
1997-07-31 |
2001-06-20 |
Wyeth Corp |
Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
DE19741873A1
(de)
*
|
1997-09-23 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6069163A
(en)
*
|
1997-10-21 |
2000-05-30 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
|
DK1027328T3
(da)
*
|
1997-10-31 |
2006-11-13 |
Aventis Pharma Ltd |
Substituerede anilider
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
US6020347A
(en)
*
|
1997-11-18 |
2000-02-01 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
AU1415099A
(en)
*
|
1997-11-18 |
1999-06-07 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
US6191171B1
(en)
|
1997-11-20 |
2001-02-20 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
US6090841A
(en)
*
|
1997-11-21 |
2000-07-18 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
|
ES2221227T3
(es)
*
|
1997-11-24 |
2004-12-16 |
MERCK & CO., INC. |
Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
|
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
|
US6407065B1
(en)
|
1998-01-23 |
2002-06-18 |
Novartis Ag |
VLA-4 antagonists
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
|
AU3716499A
(en)
*
|
1998-04-21 |
1999-11-08 |
Aventis Pharma Limited |
Substituted diamines and their use as cell adhesion inhibitors
|
|
DE19821483A1
(de)
|
1998-05-14 |
1999-11-18 |
Hoechst Marion Roussel De Gmbh |
Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DK1082302T3
(da)
|
1998-05-28 |
2004-04-26 |
Biogen Inc |
En VLA-4-inhibitor: oMePUPA-V
|
|
GB9811969D0
(en)
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
AU1915399A
(en)
*
|
1998-07-10 |
2000-02-01 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
GB9916374D0
(en)
|
1998-07-23 |
1999-09-15 |
Zeneca Ltd |
Chemical compounds
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9826174D0
(en)
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9828074D0
(en)
*
|
1998-12-18 |
1999-02-17 |
Glaxo Group Ltd |
Therapeutically useful compounds
|
|
WO2000039103A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Aventis Pharma Limited |
Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
|
|
US6407066B1
(en)
|
1999-01-26 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
DE19922462A1
(de)
|
1999-05-17 |
2000-11-23 |
Aventis Pharma Gmbh |
Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6518283B1
(en)
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
|
RU2264386C2
(ru)
*
|
1999-06-30 |
2005-11-20 |
Дайити Фармасьютикал Ко., Лтд. |
Соединения ингибиторы vla-4
|
|
BR0012068A
(pt)
*
|
1999-06-30 |
2002-05-14 |
Daiichi Seiyaku Co |
Compostos inibidores de vla-4
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
ES2270868T3
(es)
*
|
1999-08-13 |
2007-04-16 |
Biogen Idec Ma Inc. |
Inhibidores de la adhesion celular.
|
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
|
AU783110B2
(en)
|
1999-12-16 |
2005-09-22 |
Biogen Ma Inc. |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
|
YU41202A
(sh)
*
|
1999-12-28 |
2005-03-15 |
Pfizer Products Inc. |
Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti
|
|
DE60130910T2
(de)
|
2000-04-17 |
2008-07-10 |
Ucb Pharma, S.A. |
Enamin-derivate als zell-adhäsionsmoleküle
|
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
|
WO2002004426A1
(en)
|
2000-07-07 |
2002-01-17 |
Celltech R & D Limited |
Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
|
|
CA2417059A1
(en)
|
2000-08-02 |
2002-02-07 |
Celltech R&D Limited |
3-substituted isoquinolin-1-yl derivatives
|
|
WO2002040021A2
(en)
*
|
2000-11-17 |
2002-05-23 |
Idenix (Cayman) Limited |
Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
|
|
US6875743B1
(en)
|
2000-11-28 |
2005-04-05 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
CA2430978C
(en)
|
2000-12-28 |
2012-05-15 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
|
DE10111877A1
(de)
|
2001-03-10 |
2002-09-12 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
GB2377933A
(en)
|
2001-07-06 |
2003-01-29 |
Bayer Ag |
Succinic acid derivatives useful as integrin antagonists
|
|
DE10137595A1
(de)
|
2001-08-01 |
2003-02-13 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
|
|
US6897538B2
(en)
*
|
2001-08-20 |
2005-05-24 |
Honeywell International, Inc. |
Micro-machined electromechanical system (MEMS) accelerometer device having arcuately shaped flexures
|
|
AR038136A1
(es)
|
2002-01-24 |
2004-12-29 |
Merck Frosst Canada Inc |
Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
|
|
AU2003284984B2
(en)
|
2002-10-30 |
2008-10-23 |
Merck Sharp & Dohme Corp. |
Gamma-aminoamide modulators of chemokine receptor activity
|
|
JP4676884B2
(ja)
|
2003-07-24 |
2011-04-27 |
第一三共株式会社 |
シクロヘキサンカルボン酸類
|
|
CN1301426C
(zh)
*
|
2003-08-19 |
2007-02-21 |
友达光电股份有限公司 |
窄边框设计的液晶显示面板及其制作方法
|
|
WO2005066124A1
(ja)
*
|
2003-12-26 |
2005-07-21 |
Daiichi Pharmaceutical Co., Ltd. |
ピロリジン誘導体の製造法
|
|
WO2005122379A2
(en)
*
|
2004-05-27 |
2005-12-22 |
The Regents Of The University Of California |
Alpha-4 beta-1 integrin ligands for imaging and therapy
|
|
US20060063828A1
(en)
*
|
2004-06-28 |
2006-03-23 |
Weingarten M D |
1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
US7140250B2
(en)
*
|
2005-02-18 |
2006-11-28 |
Honeywell International Inc. |
MEMS teeter-totter accelerometer having reduced non-linearty
|
|
EP1961750B1
(en)
|
2005-12-13 |
2013-09-18 |
Daiichi Sankyo Company, Limited |
Vla-4 inhibitory drug
|
|
AU2008219007A1
(en)
|
2007-02-20 |
2008-08-28 |
Merrimack Pharmaceuticals, Inc. |
Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
|
|
JP5327762B2
(ja)
|
2007-12-14 |
2013-10-30 |
プルマジェン セラピューティクス（アズマ）リミテッド |
インドールおよびその治療的使用
|
|
JP5639039B2
(ja)
|
2008-04-11 |
2014-12-10 |
メリマック ファーマシューティカルズ インコーポレーティッド |
ヒト血清アルブミンリンカーおよびそのコンジュゲート
|
|
WO2010031183A1
(en)
|
2008-09-22 |
2010-03-25 |
Merck Frosst Canada Ltd. |
Indole derivatives as crth2 receptor antagonists
|
|
SG172857A1
(en)
|
2009-02-09 |
2011-08-29 |
Supergen Inc |
Pyrrolopyrimidinyl axl kinase inhibitors
|
|
BRPI1005327A2
(pt)
|
2009-02-17 |
2019-09-24 |
Chiesi Farm Spa |
derivados de triazolopiridina como inibidores de p38 map quinase
|
|
GB0902648D0
(en)
|
2009-02-17 |
2009-04-01 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
MA33134B1
(fr)
|
2009-02-24 |
2012-03-01 |
Merck Canada Inc |
Derives d'indole en tant qu'antagonistes du recepteur crth2
|
|
MY159958A
(en)
*
|
2009-12-18 |
2017-02-15 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
|
GB201009731D0
(en)
|
2010-06-10 |
2010-07-21 |
Pulmagen Therapeutics Inflamma |
Kinase inhibitors
|
|
WO2012031228A2
(en)
|
2010-09-02 |
2012-03-08 |
The Regents Of The University Of California |
Llp2a-bisphosphonate conjugates for osteoporosis treatment
|
|
US8927559B2
(en)
|
2010-10-11 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Quinazolinone-type compounds as CRTH2 antagonists
|
|
BR112013015397A2
(pt)
|
2010-12-23 |
2016-09-20 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, uso de um composto
|
|
WO2012151137A1
(en)
|
2011-05-04 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
|
PH12013502619A1
(en)
|
2011-06-17 |
2014-02-17 |
Merck Sharp & Dohme |
Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators
|
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
MY167216A
(en)
|
2011-12-09 |
2018-08-14 |
Chiesi Farm Spa |
Kinase inhibitors
|
|
BR112014013178A2
(pt)
|
2011-12-09 |
2017-06-13 |
Chiesi Farm Spa |
composto, composição farmacêutica e uso de um composto
|
|
SG11201402985VA
(en)
|
2011-12-09 |
2014-08-28 |
Chiesi Farma Spa |
Kinase inhibitors
|
|
RU2015151886A
(ru)
|
2013-06-06 |
2017-06-08 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Ингибиторы киназ
|
|
CN104817615A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd05及其制备方法和应用
|
|
CN104817613A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd06及其制备方法和应用
|
|
CN104817625A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd03及其制备方法和应用
|
|
CN104817622A
(zh)
*
|
2014-01-30 |
2015-08-05 |
陈光健 |
寡肽cd04及其制备方法和应用
|
|
CN105294830A
(zh)
*
|
2014-06-18 |
2016-02-03 |
陈光健 |
一种二肽分子及其制备方法和应用
|
|
WO2017066454A2
(en)
|
2015-10-14 |
2017-04-20 |
X-Therma, Inc. |
Compositions and methods for reducing ice crystal formation
|
|
TW201720828A
(zh)
|
2015-11-23 |
2017-06-16 |
赫孚孟拉羅股份公司 |
治療性化合物及組合物以及其使用方法
|
|
MA44131A
(fr)
|
2015-12-23 |
2021-05-26 |
Chiesi Farm Spa |
Dérivés de 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urée et leur utlisation en tant qu'inhibiteurs de p38 mapk
|
|
TW201730189A
(zh)
|
2015-12-23 |
2017-09-01 |
吉斯藥品公司 |
激酶抑制劑
|
|
AR107163A1
(es)
|
2015-12-23 |
2018-03-28 |
Chiesi Farm Spa |
Inhibidores de quinasa
|
|
JP7034942B2
(ja)
|
2016-05-05 |
2022-03-14 |
エフ．ホフマン－ラ ロシュ アーゲー |
ピラゾール誘導体、その組成物及び治療的使用
|
|
BR112019004486A2
(pt)
|
2016-09-06 |
2019-05-28 |
F.Hoffmann-La Roche Ag |
compostos de 8-(azetidin-1-il)-[1,2,4] triazolo [1,5a] piridinil, composições e métodos de uso dos mesmos
|
|
EP3939989A1
(en)
|
2016-11-11 |
2022-01-19 |
Zealand Pharma A/S |
Cyclic peptides multimers targeting alpha 4beta 7 integrin
|
|
MX2019007339A
(es)
|
2016-12-29 |
2019-09-06 |
Hoffmann La Roche |
Compuestos de pirazolopirimidina y metodos de uso de los mismos.
|
|
WO2018140510A1
(en)
|
2017-01-25 |
2018-08-02 |
Biogen Ma Inc. |
Compositions and methods for treatment of stroke and other cns disorders
|
|
JP2020510061A
(ja)
|
2017-03-14 |
2020-04-02 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ピラゾロクロロフェニル化合物、組成物及びその使用方法
|
|
KR20200015540A
(ko)
|
2017-05-10 |
2020-02-12 |
인사이클 세라퓨틱스, 인코포레이티드 |
α4β7 인테그린을 타겟팅하는 호모데틱 사이클릭 펩타이드
|
|
WO2018215390A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
|
JP7256757B2
(ja)
|
2017-05-22 |
2023-04-12 |
エフ． ホフマン－ラ ロシュ アーゲー |
処置用化合物及び組成物、並びにその使用方法
|
|
US10364245B2
(en)
|
2017-06-07 |
2019-07-30 |
Chiesi Farmaceutici S.P.A. |
Kinase inhibitors
|
|
WO2019139714A1
(en)
|
2018-01-15 |
2019-07-18 |
Genentech, Inc. |
Pyrazolopyrimidine compounds as jak inhibitors
|
|
ES2987796T3
(es)
|
2018-10-30 |
2024-11-18 |
Gilead Sciences Inc |
Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
|
|
WO2020092401A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
|
|
WO2020092394A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
DK3873884T3
(da)
|
2018-10-30 |
2025-02-17 |
Gilead Sciences Inc |
3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
|
|
WO2020143793A1
(zh)
|
2019-01-10 |
2020-07-16 |
石药集团中奇制药技术（石家庄）有限公司 |
杂环化合物盐及其应用
|
|
CN114026096B
(zh)
|
2019-06-18 |
2025-02-07 |
豪夫迈·罗氏有限公司 |
四唑取代的吡唑并嘧啶类jak激酶抑制剂及其用途
|
|
JP7657740B2
(ja)
|
2019-06-18 |
2025-04-07 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
Ｊａｋキナーゼのピラゾロピリミジンスルホン阻害剤およびその使用
|
|
EP3986899A1
(en)
|
2019-06-18 |
2022-04-27 |
F. Hoffmann-La Roche AG |
Pyrazolopyrimidine aryl ether inhibitors of jak kinases and uses thereof
|
|
AU2020329207B2
(en)
|
2019-08-14 |
2024-02-29 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
EP4284804A1
(en)
|
2021-01-26 |
2023-12-06 |
Schrödinger, Inc. |
Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders
|